본문 바로가기
KERD
논문KCI 등재

The Role of Endothelial Dysfunction in the Pathophysiology and Cerebrovascular Effects of Migraine: A Narrative Review

Matteo Paolucci|Claudia Altamura|Fabrizio Vernieri
대한신경과학회 (Korean Neurological Association)|2021.04|Journal of Clinical Neurology|제17권 제2호|pp. 164-175

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

inflammationthrombosishypercoagulabilityvasoconstrictionvasodilatation

초록

Background and Purpose Migraine is a complex neurovascular disorder whose triggers are not entirely understood. Endothelial dysfunction might play a role in migraine, and there have been numerous reports on endothelium dysfunction and migraine pathophysiology, but their reciprocal cause–effect relationship remains unclear. This review reports the current evidence on endothelium dysfunction, its link with migraine, and its possible consequences for cerebral hemodynamics. Methods We performed a systematic literature search of PubMed up to March 2020. We included 115 articles in a narrative review. Results Several studies have demonstrated that endothelium dysfunction may play an important role in migraine. Despite the lack of specific biomarkers, there is evidence of oxidative stress and inflammation—two of the primary causes of endothelial damage—in migraine. The main consequences of endothelial dysfunction are increased vascular tone, thrombosis, inflammation, and increased vascular permeability. As a consequence of oxidative stress, the activity of endothelin-1 is not counterbalanced by nitric oxide (NO), whose levels decrease to lead to vasoconstriction and a possible contribution to cortical spreading depression. NO is involved in pain perception via the cyclic guanosine monophosphate (cGMP) pathway and the induction of calcitonin gene-related peptide. Oxidative stress may induce a hypercoagulable state that mainly affects platelet function through different mechanisms. Endothelial dysfunction seems to be particularly pronounced in migraine with aura (MA). Endothelial dysfunction in migraine particularly involves intracranial vessels, since flow-mediated dilation cannot detect overt peripheral vascular dysfunction. Conclusions Endothelial dysfunction is a vascular risk marker. How it impacts migraine, and particularly MA, needs to be understood better by defining its possible role in increasing the stroke risk in migraine patients.

Abstract

Background and Purpose Migraine is a complex neurovascular disorder whose triggers are not entirely understood. Endothelial dysfunction might play a role in migraine, and there have been numerous reports on endothelium dysfunction and migraine pathophysiology, but their reciprocal cause–effect relationship remains unclear. This review reports the current evidence on endothelium dysfunction, its link with migraine, and its possible consequences for cerebral hemodynamics. Methods We performed a systematic literature search of PubMed up to March 2020. We included 115 articles in a narrative review. Results Several studies have demonstrated that endothelium dysfunction may play an important role in migraine. Despite the lack of specific biomarkers, there is evidence of oxidative stress and inflammation—two of the primary causes of endothelial damage—in migraine. The main consequences of endothelial dysfunction are increased vascular tone, thrombosis, inflammation, and increased vascular permeability. As a consequence of oxidative stress, the activity of endothelin-1 is not counterbalanced by nitric oxide (NO), whose levels decrease to lead to vasoconstriction and a possible contribution to cortical spreading depression. NO is involved in pain perception via the cyclic guanosine monophosphate (cGMP) pathway and the induction of calcitonin gene-related peptide. Oxidative stress may induce a hypercoagulable state that mainly affects platelet function through different mechanisms. Endothelial dysfunction seems to be particularly pronounced in migraine with aura (MA). Endothelial dysfunction in migraine particularly involves intracranial vessels, since flow-mediated dilation cannot detect overt peripheral vascular dysfunction. Conclusions Endothelial dysfunction is a vascular risk marker. How it impacts migraine, and particularly MA, needs to be understood better by defining its possible role in increasing the stroke risk in migraine patients.

참고문헌 (115)

  1. Ferrari MD, "Migraine pathophysiology : lessons from mouse models and human genetics", Lancet Neurol, 14, pp.65~80 (2015)
  2. Gormley P, "Meta-analysis of 375, 000 individuals identifies 38 susceptibility loci for migraine", Nat Genet, 48, pp.856~866 (2016)
  3. Roquer J, "Endothelial dysfunction, vascular disease and stroke: the ARTICO study", Cerebrovasc Dis, 27(Suppl 1), pp.25~37 (2009)
  4. Biswas SK, "Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox?", Oxid Med Cell Longev, 2016, pp.5698931~ (2016)
  5. Yıldırım S, "Paraoxonase 1 gene polymorphisms, paraoxonase", arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine, 2011, pp.29, 549~554
  6. Tuncel D, "Oxidative stress in migraine with and without aura", Biol Trace Elem Res, 126, pp.92~97 (2008)
  7. Borkum JM, "The migraine attack as a homeostatic, neuroprotective response to brain oxidative stress : preliminary evidence for a theory", Headache, 58, pp.118~135 (2018)
  8. Ghosh J, "Investigation of TNFA 308G > A and TNFB 252G > A polymorphisms in genetic susceptibility to migraine", J Neurol, 257, pp.898~904 (2010)
  9. González-Quintanilla V, "Systemic and cerebral endothelial dysfunction in chronic migraine. A case-control study with an active comparator", Cephalalgia, 36, pp.552~560 (2016)
  10. Yilmaz Avci A, "Migraine and subclinical atherosclerosis : endothelial dysfunction biomarkers and carotid intima-media thickness : a case-control study", Neurol Sci, 40, pp.703~711 (2019)
  11. Empl M, "T-cell subsets and expression of integrins in peripheral blood of patients with migraine", Cephalalgia, 19, pp.713~717 (1999)
  12. Zeller JA, "Platelet-leukocyte interaction and platelet activation in migraine : a link to ischemic stroke?", J Neurol Neurosurg Psychiatry, 75, pp.984~987 (2004)
  13. Tietjen GE, "Platelet dysfunction and stroke in the female migraineur", Curr Pain Headache Rep, 13, pp.386~391 (2009)
  14. Gabrielli M, "High prevalence of antiendothelial cell antibodies in migraine", Headache, 42, pp.385~386 (2002)
  15. Oterino A, "The relationship between homocysteine and genes of folaterelated enzymes in migraine patients", Headache, 50, pp.99~168 (2010)
  16. Michalak S, "The levels of circulating proangiogenic factors in migraineurs", Neuromolecular Med, 19, pp.510~517 (2017)
  17. Rodríguez-Osorio X, "Endothelial progenitor cells : a new key for endothelial dysfunction in migraine", Neurology, 79, pp.474~479 (2012)
  18. Hill JM, "Circulating endothelial progenitor cells, vascular function, and cardiovascular risk", N Engl J Med, 348, pp.593~600 (2003)
  19. Herbrig K, "Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells", Ann Rheum Dis, 65, pp.157~163 (2006)
  20. Lee ST, "Decreased number and function of endothelial progenitor cells in patients with migraine", Neurology, 70, pp.1510~1517 (2008)
  21. Oterino A, "Analysis of endothelial precursor cells in chronic migraine : a case-control study", Cephalalgia, 33, pp.236~244 (2013)
  22. Liman TG, "Stromal cellderived factor-1 alpha is decreased in women with migraine with aura", Headache, 56, pp.1274~1279 (2016)
  23. Boulanger CM, "Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction", Circulation, 104, pp.2649~2652 (2001)
  24. Liman TG, "Circulating endothelial microparticles in female migraineurs with aura", Cephalalgia, 35, pp.88~94 (2015)
  25. Fischer M, "Markers of endothelial function in migraine patients : results from a bi-center prospective study", Cephalalgia, 35, pp.877~885 (2015)
  26. Domínguez C, "Iron deposition in periaqueductal gray matter as a potential biomarker for chronic migraine", Neurology, 92, pp.e1076~ (2019)
  27. Domínguez-Vivero C, "Pentraxin 3(PTX3) : a molecular marker of endothelial dysfunction in chronic migraine", J Clin Med, 9, pp.849~ (2020)
  28. Jacobsen LM, "Urinary albumin excretion as a marker of endothelial dysfunction in migraine sufferers : the HUNT Study, Norway", BMJ Open, 3, pp.e003268~ (2013)
  29. Tietjen GE, "Migraine as a systemic vasculopathy", Cephalalgia, 29, pp.987~996 (2009)
  30. Pradhan AA, "Targeted nitric oxide synthase inhibitors for migraine", Neurotherapeutics, 15, pp.391~401 (2018)
  31. Thomsen LL, "Nitric oxide in primary headaches", Curr Opin Neurol, 14, pp.315~321 (2001)
  32. Lee TJ, "Nitric oxide and the cerebral vascular function", J Biomed Sci, 7, pp.16~26 (2000)
  33. Schmuck K, "Activation of meningeal 5-HT2B receptors : an early step in the generation of migraine headache?", Eur J Neurosci, 8, pp.959~967 (1996)
  34. Wei EP, "Calcitonin generelated peptide mediates nitroglycerin and sodium nitroprussideinduced vasodilation in feline cerebral arterioles", Circ Res, 70, pp.1313~1319 (1992)
  35. Borkum JM, "CGRP and brain functioning : cautions for migraine treatment", Headache, 59, pp.1339~1357 (2019)
  36. Akerman S, "Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin generelated peptide induced dilation of dural meningeal vessels", Br J Pharmacol, 137, pp.62~68 (2002)
  37. Bourque SL, "The interaction between endothelin-1 and nitric oxide in the vasculature : new perspectives", Am J Physiol Regul Integr Comp Physiol, 300, pp.R1288~ (2011)
  38. Iljazi A, "The role of endothelin in the pathophysiology of migraine-a systematic review", Curr Pain Headache Rep, 22, pp.27~ (2018)
  39. Kallela M, "Endothelin in migraine patients", Cephalalgia, 18, pp.329~332 (1998)
  40. Bianchi A, "Endothelial, haemostatic and haemorheological modifications in migraineurs", Artery, 22, pp.93~100 (1996)
  41. Hamed SA, "Vascular risk factors, endothelial function, and carotid thickness in patients with migraine : relationship to atherosclerosis", J Stroke Cerebrovasc Dis, 19, pp.92~103 (2010)
  42. Gallai V, "Endothelin 1 in migraine and tension-type headache", Acta Neurol Scand, 89, pp.47~55 (1994)
  43. Joseph EK, "Role of endothelial cells in antihyperalgesia induced by a triptan and β-blocker", Neuroscience, 232, pp.83~89 (2013)
  44. Dreier JP, "Endothelin-1 potently induces Leão's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura?", Brain, 125(Pt 1), pp.102~112 (2002)
  45. Dreier JP, "Endothelin-1-induced spreading depression in rats is associated with a microarea of selective neuronal necrosis", Exp Biol Med(Maywood), 232, pp.204~213 (2007)
  46. Hougaard A, "Intravenous endothelin-1 infusion does not induce aura or headache in migraine patients with aura", Headache, 60, pp.724~734 (2020)
  47. Hansen JM, "Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura", Cephalalgia, 30, pp.1179~1186 (2010)
  48. Christiansen I, "Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura", Cephalalgia, 19, pp.660~667 (1999)
  49. Butt JH, "Induction of migraine-like headache, but not aura, by cilostazol in patients with migraine with aura", Brain, 141, pp.2943~2951 (2018)
  50. Read SJ, "Enhanced nitric oxide release during cortical spreading depression following infusion of glyceryl trinitrate in the anaesthetized cat", Cephalalgia, 17, pp.159~165 (1997)
  51. Read SJ, "SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat", Cephalalgia, 20, pp.92~99 (2000)
  52. Read SJ, "Sumatriptan modifies cortical free radical release during cortical spreading depression : a novel antimigraine action for sumatriptan?", Brain Res, 870, pp.44~53 (2000)
  53. Lassen LH, "Nitric oxide synthase inhibition in migraine", Lancet, 349, pp.401~402 (1997)
  54. Lassen LH, "Nitric oxide synthase inhibition : a new principle in the treatment of migraine attacks", Cephalalgia, 18, pp.27~32 (1998)
  55. Johnson KW, "Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine(mCPP)involves nitric oxide and 5-HT2B receptor activation", Cephalalgia, 23, pp.117~123 (2003)
  56. Bagdy G, "Headache-type adverse effects of NO donors : vasodilation and beyond", Br J Pharmacol, 160, pp.20~35 (2010)
  57. Ferrari LF, "Mechanisms mediating nitroglycerin-induced delayed-onset hyperalgesia in the rat", Neuroscience, 317, pp.121~129 (2016)
  58. Ciancarelli I, "Urinary nitric oxide metabolites and lipid peroxidation byproducts in migraine", Cephalalgia, 23, pp.39~42 (2003)
  59. Guldiken B, "Asymmetric dimethylarginine and nitric oxide levels in migraine during the interictal period", J Clin Neurosci, 16, pp.672~674 (2009)
  60. Silva FA, "Endothelial function in patients with migraine during the interictal period", Headache, 47, pp.45~51 (2007)
  61. Napoli R, "Vascular smooth muscle cell dysfunction in patients with migraine", Neurology, 72, pp.2111~2114 (2009)
  62. Vanmolkot FH, "Endothelial function in migraine : a cross-sectional study", BMC Neurol, 10, pp.119~ (2010)
  63. Napoli R, "Migraine attack restores the response of vascular smooth muscle cells to nitric oxide but not to norepinephrine", World J Cardiol, 5, pp.375~381 (2013)
  64. Tietjen GE, "Migraine and biomarkers of endothelial activation in young women", Stroke, 40, pp.2977~2982 (2009)
  65. Uzar E, "Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine", J Headache Pain, 12, pp.239~243 (2011)
  66. Erdélyi-Bótor S, "Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions", Cephalalgia, 37, pp.571~580 (2017)
  67. Butt JH, "Endothelial function in migraine with aura-a systematic review", Headache, 55, pp.35~54 (2015)
  68. Vanmolkot FH, "Altered arterial function in migraine of recent onset", Neurology, 68, pp.1563~1570 (2007)
  69. Vernieri F, "Patients with migraine with aura have increased flow mediated dilation", BMC Neurol, 10, pp.18~ (2010)
  70. Perko D, "Associations between cerebral and systemic endothelial function in migraine patients : a post-hoc study", BMC Neurol, 11, pp.146~ (2011)
  71. Yetkin E, "Increased dilator response to nitrate and decreased flow-mediated dilatation in migraineurs", Headache, 47, pp.104~110 (2007)
  72. Heshmat-Ghahdarijani K, "Endothelial function in patients with migraine without aura during the interictal period", Int J Prev Med, 6, pp.2~ (2015)
  73. Sabri MR, "Endothelial dysfunction state in migraine headache and neutrally mediated syncope in children and young adults", J Res Med Sci, 20, pp.771~776 (2015)
  74. Dogru MT, "Endothelial and autonomic functions in patients with migraine", Pain Med, 21, pp.e222~ (2020)
  75. Rajan R, "Interictal cerebral and systemic endothelial dysfunction in patients with migraine : a case-control study", J Neurol Neurosurg Psychiatry, 86, pp.1253~1257 (2015)
  76. Larsen JS, "Migraine and endothelial function : the HUNT3 Study", Cephalalgia, 36, pp.1341~1349 (2016)
  77. Liman TG, "Peripheral endothelial function and arterial stiffness in women with migraine with aura : a case-control study", Cephalalgia, 32, pp.459~466 (2012)
  78. Dogan A, "The effect of prophylactic migraine treatment on arterial stiffness", Blood Press, 24, pp.222~229 (2015)
  79. Jiménez Caballero PE, "Peripheral endothelial function and arterial stiffness in patients with chronic migraine : a case-control study", J Headache Pain, 14, pp.8~ (2013)
  80. Houston DS, "Serotonin and the vascular system. Role in health and disease, and implications for therapy", Drugs, 31, pp.149~163 (1986)
  81. Riad M, "Endothelial expression of the 5-hydroxytryptamine1B antimigraine drug receptor in rat and human brain microvessels", Neuroscience, 86, pp.1031~1035 (1998)
  82. Nilsson T, "Contractile 5-HT1B receptors in human cerebral arteries : pharmacological characterization and localization with immunocytochemistry", Br J Pharmacol, 128, pp.1133~1140 (1999)
  83. de Hoon JN, "Vascular effects of 5-HT1B", 1D-receptor agonists in patients with migraine headaches, 2000, pp.68, 418~426
  84. Segelcke D, "Putative role of 5-HT2B receptors in migraine pathophysiology", Cephalalgia, 37, pp.365~371 (2017)
  85. Fozard JR, "The 5-hydroxytryptamine-nitric oxide connection : the key link in the initiation of migraine?", Arch Int Pharmacodyn Ther, 329, pp.111~119 (1995)
  86. Cieślak M, "The role of purinergic signaling in the etiology of migraine and novel antimigraine treatment", Purinergic Signal, 11, pp.307~316 (2015)
  87. Burnstock G, "Purinergic signaling in the cardiovascular system", Circ Res, 120, pp.207~228 (2017)
  88. Kis B, "Cerebral endothelial cells are a major source of adrenomedullin", J Neuroendocrinol, 14, pp.283~293 (2002)
  89. Iring A, "Shear stress-induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure", J Clin Invest, 129, pp.2775~2791 (2019)
  90. Lang MG, "Mechanisms of adrenomedullin-induced dilatation of cerebral arterioles", Stroke, 28, pp.181~185 (1997)
  91. Li FJ, "Adrenomedullin : an important participant in neurological diseases", Neural Regen Res, 15, pp.1199~1207 (2020)
  92. Petersen KA, "Effect of adrenomedullin on the cerebral circulation : relevance to primary headache disorders", Cephalalgia, 29, pp.23~30 (2009)
  93. Sarrel PM, "The differential effects of oestrogens and progestins on vascular tone", Hum Reprod Update, 5, pp.205~209 (1999)
  94. Martin VT, "Ovarian hormones and migraine headache : understanding mechanisms and pathogenesis--part I", Headache, 46, pp.3~23 (2006)
  95. Wolf ME, "Functional TCD : regulation of cerebral hemodynamics--cerebral autoregulation, vasomotor reactivity, and neurovascular coupling", Front Neurol Neurosci, 36, pp.40~56 (2015)
  96. Vernieri F, "Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity", Stroke, 30, pp.593~598 (1999)
  97. Vernieri F, "Increased cerebral vasomotor reactivity in migraine with aura: an autoregulation disorder? A transcranial doppler and nearinfrared spectroscopy study", Cephalalgia, 28, pp.689~695 (2008)
  98. Fiermonte G, "Cerebrovascular CO2 reactivity in migraine with aura and without aura. A transcranial Doppler study", Acta Neurol Scand, 92, pp.166~169 (1995)
  99. Silvestrini M, "Basilar and middle cerebral artery reactivity in patients with migraine", Headache, 44, pp.29~34 (2004)
  100. Lee MJ, "Paradoxical association between age and cerebrovascular reactivity in migraine : a cross-sectional study", J Neurol Sci, 398, pp.204~209 (2019)
  101. Altamura C, "Right-to-left shunts and hormonal therapy influence cerebral vasomotor reactivity in patients with migraine with aura", PLoS One, 14, pp.e0220637~ (2019)
  102. Anzola GP, "Is migraine associated with right-to-left shunt a separate disease? Results of the SAM study", Cephalalgia, 28, pp.360~366 (2008)
  103. Altamura C, "Erenumab does not alter cerebral hemodynamics and endothelial function in migraine without aura", Cephalalgia, 41, pp.90~98 (2021)
  104. Perko D, "Cerebrovascular reactivity to L-arginine in the anterior and posterior cerebral circulation in migraine patients", Acta Neurol Scand, 124, pp.269~274 (2011)
  105. Jemima SA Dzator, "Profiling cerebrovascular function in migraine: A systematic review and meta-analysis", Journal of Cerebral Blood Flow & Metabolism, 41(5), pp.919~944 (2021), SAGE Publications[DOI]
  106. Webb AJS, "Confounding of cerebral blood flow velocity by blood pressure during breath holding or hyperventilation in transient ischemic attack or stroke", Stroke, 51, pp.468~474 (2020)
  107. Tietjen GE, "Migraine and vascular disease biomarkers : a population-based case-control study", Cephalalgia, 38, pp.511~518 (2018)
  108. Yücel M, "Serum levels of endocan, claudin-5 and cytokines in migraine", Eur Rev Med Pharmacol Sci, 20, pp.930~936 (2016)
  109. Tietjen GE, "Increased von Willebrand factor in migraine", Neurology, 57, pp.334~336 (2001)
  110. Cesar JM, "Increased levels of plasma von Willebrand factor in migraine crisis", Acta Neurol Scand, 91, pp.412~413 (1995)
  111. Tietjen GE, "Altered hemostasis in migraineurs studied with a dynamic flow system", Thromb Res, 119, pp.217~222 (2007)
  112. Tietjen GE, "Association of von Willebrand factor activity with ACE I", D and MTHFR C677T polymorphisms in migraine, 2009, pp.29, 960~968
  113. de Villiers S, "A possible role of amyloidogenic blood clotting in the evolving haemodynamics of female migraine-with-aura : results from a pilot study", Front Neurol, 10, pp.1262~ (2019)
  114. Peroutka SJ, "Neurogenic inflammation and migraine : implications for the therapeutics", Mol Interv, 5, pp.304~311 (2005)
  115. Mason BN, "Vascular contributions to migraine : time to revisit?", Front Cell Neurosci, 12, pp.233~ (2018)

관련 논문AI추천

The Migraine–Stroke ConnectionChin-Sang Chung, Chungbin Lee, Mi ji Lee대한뇌졸중학회 · 대한뇌졸중영문학회지2016 · 제18권 제2호Sensitization of the Trigeminovascular Pathway: Perspective and Implications to Migraine PathophysiologyCarolyn Bernstein, Rami Burstein대한신경과학회 · Journal of Clinical Neurology2012 · 제8권 제2호Oxygen Therapy in Cluster Headache, Migraine, and Other Headache Disorders모희정, 정수지, 조수진, Todd D Rozen대한신경과학회 · Journal of Clinical Neurology2022 · 제18권 제3호Is There an Association between Migraine and Gastrointestinal Disorders?Christian Saleh, Michael Doulberis, Stefan Beyenburg대한신경과학회 · Journal of Clinical Neurology2017 · 제13권 제3호Increased Risk of Cardio-Cerebrovascular Diseases in Migraine Patients: A Nationwide Population-Based, Longitudinal Follow-Up Study in South Korea윤석, 강동우, 김형준, 배윤종, 이승재, Cheryl D Bushnell대한신경과학회 · Journal of Clinical Neurology2022 · 제18권 제3호두개경유도플러초음파를 이용한 성인 여성 무조짐편두통 환자의 식사 상태에 따른 뇌혈관반응성 변화박선아, 박정호, 성기범, 이태경대한임상신경생리학회 · Annals of Clinical Neurophysiology2012 · 제14권 제1호

이 간행물의 다른 논문 (25건)

Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2IA Sri Wijayanti, DPG Purwa Samatra, Putu Lohita Rahmawati, Kumara Tini, Ni Made Susilawathipp. 155-163Systematic Literature Review of Psychiatric Comorbidities in Adults with EpilepsyChristopher J Burant, Elaine Lu, Nataliya Pyatka, Martha Sajatovicpp. 176-186Clinical, Imaging, and Laboratory Markers of Premanifest Spinocerebellar Ataxia 1, 2, 3, and 6: A Systematic Review이경민, 이지영, 김률, Dong-Hoi Kimpp. 187-199Association between Heart Failure and Clinical Prognosis in Patients with Acute Ischemic Stroke: A Retrospective Cohort StudyLuis Alfonso Barragán Pedraza, Jenny Carolina Sánchez Casas, Fernán del Cristo Mendoza Beltrán, Fabián Cortés Muñoz, Javier Francisco Torres Zafra, Jose Luis Lozano Villanuevapp. 200-205Association between Serum Insulin-Like Growth Factor-1 and Neurological Severity in Acute Ischemic Stroke임재성, 오미선, 이지은, 유경호, 이병철, 김진혁, 이민우, 이정재pp. 206-212
원문 보기